Dakang Xu works in the Centre for Cancer Research at the Hudson Institute of Medical Research. The main focus of his research team is to characterise modulation of key regulators that affect inflammatory responses and tumour progression, through the function of immune cell subsets and cytokines in cancer and inflammatory diseases. This work has led to 40 peer-reviewed publications in high impact journals, including Nat Immunol, Immunity, Nat Commun, PNAS, EMBO J and Cancer Res. These include 15 papers as senior and corresponding author.